048870 — Synergy Innovation Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual income statement for Synergy Innovation Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	30,705	86,539	83,215	90,605	113,050
Cost of Revenue
Gross Profit	6,181	39,541	31,603	38,104	50,337
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	29,482	63,612	68,230	74,401	94,020
Operating Profit	1,223	22,927	14,985	16,204	19,030
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-1,561	14,674	26,711	21,797	16,147
Provision for Income Taxes
Net Income After Taxes	-1,561	25,391	7,653	18,144	11,185
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	5,719	16,128	2,305	10,371	3,011
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,719	16,128	2,305	10,371	3,011
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-72.1	231	29.2	121	39.1
Dividends per Share